News
More than 14 million children did not receive a single vaccine last year — about the same number as the year before — ...
As science soars with game-changing HIV tools, a funding crisis threatens to ground progress "We come together at a pivotal time for the HIV response, one defined by both incredible scientific ...
Global infant vaccination levels have stabilized after shrinking during the COVID crisis, the UN said Tuesday, but it warned ...
Global infant vaccination levels have stabilised after shrinking during the Covid crisis, the UN said Tuesday, but it warned that misinformation and drastic aid cuts were deepening dangerous coverage ...
2h
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
2h
The Kenya Times on MSNWHO Awards Uhuru Kenyatta for Championing Pandemic AgreementFormer President Uhuru Kenyatta has received an award from the World Health Organization (WHO). WHO formally recognized the ...
2h
United News of Bangladesh on MSN14 million children missed all vaccinations in 2024, UN warnsAn estimated 14 million children worldwide received no vaccines at all in 2024, mirroring figures from the previous year, according to a joint report by the World Health Organization (WHO) and UNICEF.
3h
TheHealthSite on MSNWhat Is Lenacapavir? All About WHO Recommended Biannual HIV Prevention DrugA breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...
The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...
The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorsement arrives amidst funding concerns, with Gilead ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
In 2024, 89% of infants worldwide—approximately 115 million—received at least one dose of a diphtheria, tetanus, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results